HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection. (Q34967056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

review article

1 reference

title

HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

author name string

Liza J Raggatt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

2185-2191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12381218 AND SRC:MED&resulttype=core&format=json

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

13 December 2019

cites work

1 reference

12 December 2020

Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation

1 reference

12 December 2020

Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy

1 reference

12 December 2020

Regulation of mesangial cell proliferation by the mevalonate pathway.

1 reference

12 December 2020

Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation

1 reference

12 December 2020

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women

1 reference

12 December 2020

The immunological synapse: a molecular machine controlling T cell activation

1 reference

12 December 2020

The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

1 reference

12 December 2020

Effects of Lovastatin on the Immune System

1 reference

12 December 2020

Adhesion molecules mediating neutrophil migration to arthritis in vivo and across endothelium and connective tissue barriers in vitro

1 reference

12 December 2020

A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists

1 reference

12 December 2020

Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.

1 reference

12 December 2020

A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8 cytotoxic T cell with apparent high affinity.

1 reference

12 December 2020

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

12 December 2020

Specific immunotherapy: one size does not fit all.

1 reference

12 December 2020

Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation

1 reference

12 December 2020

The induction of major histocompatibility complex class II expression is sufficient for the direct activation of human CD4 T cells by porcine vascular endothelial cells

1 reference

12 December 2020

Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group

1 reference

12 December 2020

T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1

1 reference

12 December 2020

Current perspectives on statins

1 reference

12 December 2020

Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients

1 reference

12 December 2020

Effect of HMG-CoA reductase inhibitors on chronic allograft rejection.

1 reference

12 December 2020

Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression

1 reference

12 December 2020

Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease

1 reference

12 December 2020

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients

1 reference

12 December 2020

Major histocompatibility complex class II deficiency: a clinical review

1 reference

12 December 2020

Inhibition of monocyte chemotactic protein-1 synthesis by statins

1 reference

12 December 2020

A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations.

1 reference

12 December 2020

Stimulation of bone formation in vitro and in rodents by statins

1 reference

12 December 2020

Pravastatin Increases Survival and Inhibits Natural Killer Cell Enhancement Factor in Liver Transplanted Rats

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro

1 reference

12 December 2020

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases

1 reference

12 December 2020

HMG-CoA reductase inhibitors and the risk of fractures

1 reference

12 December 2020

How selection shapes variation of the human major histocompatibility complex: a review

1 reference

12 December 2020

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

1 reference

12 December 2020

T-cell-receptor affinity and thymocyte positive selection

1 reference

12 December 2020

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial

1 reference

12 December 2020

Pharmacology of competitive inhibitors of HMG-CoA reductase.

1 reference

12 December 2020

Topology of the CD2–CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells

1 reference

12 December 2020

Hyperlipidemia after renal transplantation--facts and potential implications

1 reference

12 December 2020

Leukocyte-endothelial adhesion molecules

1 reference

12 December 2020

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 reference

12 December 2020

Helper T cell differentiation, inside and out.

1 reference

12 December 2020

Unresponsiveness to 2,4-dinitro-1-fluoro-benzene after treatment with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1 during sensitization.

1 reference

12 December 2020